Drugs that are on the market to treat erectile dysfunction (ED) could have another use–they might be able to protect the liver from damage caused by sepsis, a systemic inflammatory response to infection, say researchers at the University of Pittsburgh School of Medicine. They recently published their findings in Science Signaling. Infection can lead to the release of chemicals that cause whole-body inflammation, which can cause life-threatening damage to organs including the liver and kidneys, explained senior investigator Timothy Billiar, M.D., professor and chair of surgery, Pitt School of Medicine. Sepsis is a leading cause of death in the intensive care unit. “Sepsis is a very challenging problem, so the possibility that we might be able to repurpose a drug that is in use and well understood is very exciting,” Dr. Billiar said. Sepsis triggers production of a protein called tumor necrosis factor, or TNF, which helps fight infection but is harmful at sustained high levels. The res…
See all stories on this topic
Male infertility has now been linked to a shorter lifespan. According to researchers, men with semen defects were found to die sooner than their fertile male counterparts, but the risk is low. The finding doesn’t mean a shorter lifespan for some men but it could mean physicians should counsel men who might be at risk. The finding, published in the journal Human Reproduction, is the result of data collected from 12,000 men between the ages 20 and 50. The researchers looked at sperm motility, shape, total sperm count and volume. Why infertility in men could shorten lifespan The reasons for the link between abnormal semen and shorter lifespan isn’t entirely clear, but could include other health risks that trigger defects in sperm production such as diabetes or abnormalities in the blood vessels of the testes. Other reasons for poor sperm quality include certain medications, alcohol and drug use and genetic abnormalities Advertisement – More Below Subscribe to EmaxHealth on YouTube Dr. Mi…
See all stories on this topic
Sexual performance issues are widespread and exceedingly common but many guys still don’t know how to handle them. Too many men let these simple issues go until they become more serious concerns than can actually require medical intervention. But if a guy deals with a problem head on and as soon as it crops up, his chances of success with natural methods increases greatly. Here we’ve gathered together three of the most common sexual performance along with the top tips to resolve them quickly and easily – BEFORE they become worrisome. Early ejaculation is absolutely the most common concerns when it comes to sexual performance. Not only is it incredibly common, it can happen to anyone at any time no matter what your physical health is like. The problem is that the condition can be triggered by just about anything and letting it go on too long can actually make it worse. Early ejaculation can be triggered by a poor diet, too much stress or even just a random stroke of bad luck….
See all stories on this topic
In September of 2015, a California man filed a lawsuit that might just change the way male enhancement supplements are marketed and perceive forever. The suit is aimed at a male enhancement drug available over the counter and while it targets only one company and specific brand, the implications could have a far reaching effect on the industry as a whole. Robert Matus is the man who has brought the suit and he’s made it a class action filing. That means that many other men who feel similarly have jumped on board, increasing the litigants in this suit. The lawsuit, filed in the Superior Court of California of San Bernardino County has been formally lodged against Premium Nutraceuticals LLC. The charge? Fraud and deception. The focus of the lawsuit is the product Vydox. This is a popular male enhancement supplement sold across several websites, including global retailers such as Amazon. The supplement claims to be able to produce harder and better erections as well as improving stamin…
See all stories on this topic